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Background.Animaland in vitro studies suggest thatvolatile anaestheticsaffect left atrial (LA)
performance. We hypothesized that human LA pump function and dimensions are altered by
volatile anaesthetics in vivo.
Methods.We performed transthoracic echocardiographic (TTE) measurements in 59 healthy
subjects (aged 18–48 yr) undergoing minor surgery under general anaesthesia. The
unpremedicated patients were randomly assigned to anaesthesia with sevoflurane,
desflurane, or isoflurane. TTE examinations were performed at baseline and after induction
of anaesthesia and upon placement of a laryngeal mask during spontaneous breathing.
After changing to intermittent positive pressure ventilation (IPPV), an additional TTE was
performed. The study focused on the velocity–time integral of late peak transmitral inflow
velocity (AVTI) and maximum LA volume.
Results. We found no evidence for relevant differences in the effects of the three volatile
anaesthetics. AVTI decreased significantly from 4.1 (1.2) cm at baseline to 3.2 (1.1) cm
during spontaneous breathing of 1 minimum alveolar concentration of volatile
anaesthetics. AVTI decreased further to 2.8 (1.0) cm after changing to IPPV. The maximum
LA volume was 45.4 (18.6) cm3 at baseline and remained unchanged during spontaneous
breathing but decreased to 34.5 (16.7) cm3 during IPPV. Other parameters of LA pump
function and dimensions decreased similarly.
Conclusions. Volatile anaesthetics reduced active LA pump function in humans in vivo.
Addition of IPPV decreased LA dimensions and further reduced LA pump function. Effects
in vivo were less pronounced than previously found in in vitro and animal studies. Further
studies are warranted to evaluate the clinical implications of these findings.
Clinical trial registration. NCT0024451.
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The left atrium (LA) plays a key role in cardiac performance. It
serves as a reservoir and passive conduit for blood entering
the LA from the pulmonary veins and filling the left ventricle
(LV) during diastole. In addition, it acts as an active booster
pump, which completes the LV filling during late diastole.1
The critical role of LA function in maintaining normal LV
filling and stroke volume becomes obvious when atrio-
ventricular coupling is disturbed or when atrial fibrillation
develops. The latter may decrease cardiac output by up to
20–25% even in healthy subjects.2 3
The cardiovascular effects of the volatile anaesthetics com-
monlyusedasacomponentofgeneral anaesthesiaare still not
fully elucidated, particularly with regard to the balance of their
beneficial and adverse cardiovascular effects. Volatile anaes-
thetics were reported to impair LV systolic function4 5 due to
interaction with intracellular Ca2+ homeostasis, whereas two
recent echocardiographic studies in healthy adults showed
that they did not relevantly affect LV systolic function at
age-adjusted minimum alveolar concentration (MAC) of 1.0.6
7 The latter studies also showed no clinically relevant negative
effect on early diastolic relaxation, whereas late diastolic func-
tion seemed to be impaired.6 7 Late diastolic filling of the LV
is mainly due to active atrial contraction. In the early stage
of LV diastolic dysfunction, LV filling becomes increasingly
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dependent on the LA booster pump, which compensates for
the impaired passive filling.1 Our knowledge about the in vivo
effects of volatile anaesthetics and/or positive pressure venti-
lation on atrial size and different atrial functions is limited. If
volatile anaesthetics, positive pressure ventilation, or both po-
tentially change atrial size and function, the interpretation of
echocardiographic studies focused on LV function must be
questioned. A former in vitro study showed an impairment of
atrial myocardium by volatile anaesthetics.8 Canine in vivo
studies showed a reduction in LA contractility by about 50%
in the presence of different volatile anaesthetics andmechan-
ical ventilation.9–11 However, animal and in vitro studies
cannot be directly transferred to the human patient during an-
aesthesia, and human in vivo data are needed.
In this study, we aimed to evaluate the effect of volatile
anaesthetics on LA dimensions and functions as evaluated
by complementary analyses of transthoracic echocardio-
graphic (TTE) examinations in a human in vivo model. We
hypothesized that—in contrast to LV systolic function7—
active LA pump function and LA dimensions will be relevantly
reduced by volatile anaesthetics during spontaneous breath-
ing, positive pressure ventilation, or both.
Methods
Patients
This study is based on electronically stored echocardiographic
data that were collected during a previously published study.7
The actual and the former study were approved by the local
ethics committee (Ethikkommission beider Basel, Basel, Switz-
erland), and written informed consent was received from a
total of 61 patients undergoing minor surgical procedures
under general anaesthesia. Exclusion criteria were any history
or signs of cardiac, pulmonary, or systemicdisease; anymedica-
tionwith cardiovasculareffects or side-effects; age,18or.50
yr, and BMI .30 kg m22. Of those enrolled, two patients were
excluded from this analysis because of diastolic dysfunction at
baseline in one patient and because the echocardiographic
data were of insufficient quality to be analysed in the other
patient, leaving 59 patients in the study (Table 1).
The study design has been described in detail before.7 In
short, patients were randomly assigned to anaesthesia with
sevoflurane, desflurane, or isoflurane. Fifty per cent of the cal-
culated fluid deficit after overnight fasting was replaced by
Ringer’s lactate before the start of the study, and a total of
66%was replaceduntil theendof the study. Patientswere con-
tinuously monitored with two-lead electrocardiogram, pulse
oximetry, and non-invasive arterial pressure measurements,
and forend-tidalCO2 tension, concentrationsof thevolatilean-
aesthetic, and body temperature. Body temperature was kept
above 368C. Hypotension, defined as a .30% decrease in sys-
tolic arterial pressure from the baseline, was treated with i.v.
boluses of 25–50 mg phenylephrine.
Three echocardiographic measurements were performed.
The first TTE (baseline) was performed in the awake and unpre-
medicated patient in a partial left lateral position. The same
position was used during all further measurements. After
completion of the baseline TTE, anaesthesia was induced by
i.v. infusion of remifentanil (Ultivaw, GlaxoSmithKline, London,
UK)deliveredbyatarget-controlled infusionsystem(Orchestra&
Base Primera, Fresenius Vial, Brezins, France) at a calculated
end-organ concentration of 2.0 ngml21. Oxygen was delivered
at 100%bya facemask. Inductionwas completed by inhalation
of sevoflurane (Sevoranew, Abbott International Ltd, Abbott
Park, IL, USA), desflurane (Supranew, Baxter, Deerfield, IL,
USA), or isoflurane (Foranew, Abbott International Ltd). No
other narcotics, opioids, or neuromuscular blocking agents
were used. After placement of a laryngealmask, the inspiratory
fraction of oxygenwasadjusted to0.4, the remifentanil infusion
stopped, and the administration of volatile anaesthetics
reduced to an end-tidal concentration corresponding to 1
MAC. The MAC value was age-adjusted according to the
formula published by Eger.12 As soonas remifentanil end-organ
concentration in the patient reached ,0.1 ng ml21 (as calcu-
lated by the target-controlled infusion system) and anaesthetic
and haemodynamic steady-state conditions were reached, a
second TTE was performed under spontaneous breathing
(step I). After completion of data acquisition, intermittent posi-
tive pressure ventilation (IPPV) was started to achieve normo-
ventilation (end-tidal CO2 4.5–5 kPa). Tidal volumes were
adjusted to 7–8 ml kg21. The concentration of the volatile an-
aesthetic was kept at 1.0 MAC. During haemodynamic
steady-state conditions, a third TTE (step II) was performed,
which completed the study. Subsequently, each patient under-
went scheduled surgery and anaesthesia, which was not influ-
enced by the study protocol.
Echocardiography
All echocardiogramswere obtainedwith a SonosTM 5500 ultra-
sonographic system and a 1.8–2.1/3.6–4.1 MHz S4 probe
(Philips Medical Systems, Best, The Netherlands). All echocar-
diographic data were digitally stored for subsequent off-line
analysis. Standard parasternal short-axis and apical four-
and two-chamber views (4-CV and 2-CV) were obtained
according to the current guidelines for TTE.13 For recordings
of pulsed-wave tissue Doppler imaging (TDI), the sample
volume was placed at the septal and lateral sides of the
Table 1 Patient characteristics. Values are mean (SD) or numbers
(%)
All subjects (n559)
Age (yr) 31 (9)
Female gender 20 (34)
Weight (kg) 71 (12)
Height (cm) 174 (9)
Body surface area (m2) 1.78 (0.21)
Haemoglobin (g litre21) 146 (16)
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mitral annulus and the presettings of the SonosTM 5000 for TDI
were used (Software Version D.1). For the pulsed-waveDoppler
recordings of the mitral inflow, the sample volume was posi-
tioned between the tips of the open mitral leaflets using
optimal alignmentwith transmitral blood flow. For the pulsed-
wave Doppler recordings of the pulmonary venous flow, the
sample volume was positioned about 1 cm within the upper
right or left pulmonary vein.
The apical 4-CVand 2-CV served for assessment of LA area,
LA length, and LA volume (Fig. 1). Measurements were per-
formed at maximum andminimum volume on the frame pre-
cedingtheopeningandclosureof themitralvalve, respectively.
Themitral annulus plane represented the inferior border of the
LA. The confluences of the pulmonary veins and the LA ap-
pendagewereexcluded fromtheLAcavity. LA lengthwasmea-
suredas thedistancebetweenthemiddleof themitral annulus
plane and the roof of the LA. The biplane LAvolumewas calcu-
lated according to the area–length model (ALM) of the LA
using the formula: LA volume (ml)¼8/3 q (A1×A2/L), where
A1 and A2 are the LA areas derived from the 4-CVand 2-CV, re-
spectively, and L is the length.14 In addition, biplane Simpson’s
method of discs (MOD) was used to calculate LA volume in the
apical 4-CV and 2-CV.14 Further Doppler variables measured
include: peak early (E) and late (A) transmitral filling velocities,
and early (e′) and late (a′) peak diastolic and peak systolic (s′)
velocities of the mitral annulus predefined as the average of
septal and lateral mitral annulus measurements obtained by
TDI (Fig. 1). Further, the velocity–time integrals of A (AVTI), E
(EVTI), and a′ wave (a′VTI) were measured from mitral inflow
and tissue Doppler measurements of the mitral annulus,
respectively. Finally, peak velocities of systolic (SPVF), diastolic
(DPVF), and atrial reverse (APVF) waves of pulmonary venous
flow were measured.15
The followingparameterswere calculated: LA fractional area
change (LA-FAC) as maximum LA area minus the minimum LA
area in the 4-CVdivided bymaximum LA area×100; LA empty-
ing fraction (LA-EF)asmaximumLAvolumeminusminimumLA
volumedividedbymaximumLAvolume×100; LA fractionof the
ventriculardiastolic fillingas [AVTI/(EVTI+AVTI)]×100; LAejection
force as 0.5×r×MAA×A2, where r is the blood density (1.06 g
cm23)andMAAthemitralannulusarea (calculatedasp×mitral
annulusdiameter in4-CV/2×mitralannulusdiameter in2-CV/2)
and A2 the square of the peak late transmitral filling velocity.16
LA reservoir volume was calculated as maximum minus
minimum LA volume; conduit volume was calculated as total
LV stroke volume minus the reservoir volume, whereby stroke
volume was estimated by the formula (EVTI+AVTI)×MAA.17 LA
active emptying volumewas estimated as AVTI×MAA.
For comparison of LA and LVperformance during anaesthe-
siawithspontaneousbreathingandIPPV,weadditionallymea-
sured theLVend-diastolicarea (LV-EDA)and theLVend-systolic
area (LV-ESA) in the parasternal short-axis view. Using these
values, we calculated the LV-FAC as [(EDA2ESA)/EDA]×100.
All variables were measured at end-expiration over three
preferably consecutive cardiac cycles and were averaged by
an experienced physician-echocardiographer blinded to all
other studydata. Due carewas taken to avoid a foreshortening
of the LA cavity in all measurements.
To determine intra- and inter-rater variabilities, a random













Fig1 LAareaandTDIparametersatbaselineandduringpositivepressureventilation. Theupper rowshowsmaximumandminimumLAarea in the
apical four-chamber viewas tissueDopplerparameters in theawakepatient (baseline). The lower rowshowsthecorrespondingLAareasand tissue
Doppler parameters during anaesthesiawith volatile anaesthetics and positive pressure ventilation (step II). LA, left atrium; TD, tissue Doppler; a′,
latepeakdiastolic velocityof themitral annulus; e′, early peakdiastolic velocityof themitral annulus; s′, peak systolic velocityof themitral annulus.
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and tissue Doppler recordings was submitted twice to the first
investigatorandonce toa second investigator. The variabilities
were thencalculatedasthemeanabsolutedifferencebetween
both readings divided by their mean and expressed as percen-
tages and their 95% confidence intervals (CIs).
Statistical analysis
The study focused on AVTI and LA maximum volume as the
primary parameter of active LA pump function and dimension,
respectively.18Noformalsamplesizecalculationwasperformed.
However, apost hocpoweranalysis showed that a sample sizeof
59 patients would allow detecting a decrease of 15% and 20%
in AVTI and maximum LA volume, respectively (a,0.05 and
b≥0.8), by one-way analysis of variance (ANOVA) for repeated
measurements followed by Bonferroni’s post hoc test.
Continuous variables are presented as mean (SD), and di-
chotomous variables as number (%). Based on the former
study,7 normal distribution of echocardiographic parameters
was assumed. To evaluate potential differences in the effects
of the volatile anaesthetics, we performed a general linear
model for repeated measurements to test differences
between the three different anaesthetics (P¼0.025 was con-
sidered significant). Influence of anaesthesia with volatile
agents and positive pressure ventilation on LA size and func-
tionwassubsequentlyanalysedbyANOVA for repeatedmeasure-
ments followed by Bonferroni’s post hoc test for differences at
step I and step II compared with baseline (P¼0.025 was con-
sidered significant). Finally, LA and LVmaximum area and sys-
tolic function (a′ vs s′ andLA-FACvsLV-FAC)19 20werecompared
afternormalization for baseline (set as100%). Again, a general
linear model for repeatedmeasurements was used to test the
differences between the LA vs the LV and at the different time
points. Influence of heart rate on echocardiographic LA para-
meters was evaluated using the Pearson’s correlation coeffi-
cient. All statistical analyses were performed using IBM SPSS
Statistics 21 (IBM Corp., Armonk, NY, USA).
Results
Haemodynamics
Mean arterial pressure decreased after administration of the
volatile anaesthetics, and heart rate increased. However, the
increase in heart rate became significant only after changing
to IPPV (Table 2). Phenylephrine but no other vasoactivemedi-
cationwas administered during the study to five patients (25–
500 mg): to four during both study steps I and II and to one
during step II only. Heart rate was negatively correlated with
LA volumes; however, correlation was weak (R≤0.4). Heart
rate was not correlated with functional parameters including
a′, a′VTI, APVF, and LA active emptying volume, but there was
a weak positive correlation with A and AVTI (R≤0.3).
Influence of different volatile anaesthetics
We found no evidence for significant differences between the
three volatile anaesthetics (sevoflurane, desflurane, and iso-
flurane) regarding their effect on LA function and dimensions.
Also, systolic LV function as evaluated by s′ and LV-FAC was
similar between all three. All P-values in the general linear
model were above the significance level of 0.025 with the ex-
ception of a′, where P¼0.007 (Supplementary Appendix S1).
However, there were no significant differences in A, AVTI, a′VTI,
and APVF. Furthermore, a′ decreased consequently in each
study step with each volatile anaesthetic (Supplementary Ap-
pendix S2). Therefore, the data fromall patients anaesthetized
with these three anaesthetics were pooled for the following
analyses.
Influence of volatile anaesthetics and IPPV
Measured and calculated echocardiographic LA parameters at
baseline and with volatile anaesthetics during spontaneous
breathing and IPPVare shown in Table 2. Active LA pump func-
tion, as evaluatedbyAVTI, decreased significantly from4.1 (1.2)
cmat baseline to 3.2 (1.1) and 2.8 (1.0) cmafter the addition of
volatile anaesthetics during spontaneous breathing and IPPV,
respectively. Similar changes were found with other echocar-
diographic parameters of active LA pump function, including
A, a′, a′VTI, LA ejection forces, and filling fraction. They were
all significantly affected by volatile anaesthetics during spon-
taneous breathing compared with baseline, and were further
impaired by IPPV, but impairment did not regularly reach stat-
istical significance compared with spontaneous breathing.
AVTI, A, a′, a′VTI, and ejection forces were similarly reduced by
30–40% from baseline to IPPV.
LA volume and area were differently affected. Minimum LA
area and volume were similar during all study steps. LA
maximum area and volume were similar at baseline and with
volatile anaesthetics during spontaneous breathing but
decreased significantly after changing to IPPV. Maximum area
and volume and also FAC and EF were reduced by 16–25%
from baseline to IPPV.
LA reservoir volume decreased only after changing to IPPV,
whereas LA active emptying volume significantly decreased
with volatile anaesthetics during spontaneous breathing
but showed no further significant decrease with IPPV. LA
conduit volume was well preserved during administration of
volatile anaesthetics with spontaneous breathing and slightly
decreased after changing of IPPV (Fig. 2). Pulmonary venous
flow velocity during LV systole (SPVF) decreased already during
spontaneous breathing and decreased further after changing
to IPPV. In contrast, the flow during LV diastole (DPVF) did not
change throughout the study.
Comparison between LA and LV dimensions and
function
For comparison of changes of LA and LV size and pump func-
tion, all values were normalized to their respective baseline
values. Pump function of the LA as evaluated by a′ and
LA-FAC decreased consequently with volatile anaesthetics
during both spontaneous breathing and IPPV,whereas systolic
function of the LVas evaluated by s′ and LV-FACdid not change
significantly at any step during administration of volatile
anaesthetics (P,0.001 and 0.001 for the general linear
model) (Fig. 3). LV-EDA was similar during all study steps,
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whereas maximum LA area in the apical 4-CV decreased with
IPPV. However, these differences did not become significant
(P¼0.143).
Inter- and intra-rater variability
Intra- and inter-rater variabilities for different echocardio-
graphic parameters are shown in Table 3. Variabilities within
the three study steps were comparable.
Discussion
Our study in healthy adults found that volatile anaesthetics
reduced active LA pump function as primarily evaluated by
AVTI but not LA minimum and maximum volume during spon-
taneous breathing. After changing from spontaneous breath-
ing to IPPV, there was a marked decrease in maximum LA
volume and a further reduction in LA pump function. Other
parameters of active LA pump function including A, a′, a′VTI,
calculated ejection forces, and active emptying volume went
in parallel with AVTI, whereas LA reservoir volume decreased
after changing to IPPV in parallel with maximum volume. In
contrast, LA conduit volume remained preserved during all
study steps.
The mechanical function of the LA plays a critical role in
cardiac performance as a reservoir, passive conduit, and active
booster pump, thereby draining the pulmonary veins and facili-
tatingLVfilling.1Theactivecontractionandpassive relaxationof
the LAmyocardiumare dependent on calcium inflow intomyo-
cardial muscle cells and the dissociation of calcium from
troponinCandactive re-uptake into thesarcoplasmic reticulum.
Volatile anaesthetics are knowntoaltercalciumhomeostasis at
several subcellular targets of themyocardial cell.21 These inter-
actions are thought to be themolecular basis for impairment of
both systolic and diastolic cardiac function by volatile anaes-
thetics.4 5 However, own previous studies have shown that dif-
ferent volatile anaesthetics including halothane, sevoflurane,
Table 2 Effects of volatile anaestheticswith spontaneous breathing and positive pressure ventilation on echocardiographic parameters of the LA.
Values are mean (SD). P-values were calculated by ANOVA for repeated measurements followed by Bonferroni’s post hoc test (*P,0.025 baseline vs
stepI; †P,0.025baselinevs stepII; ‡P,0.025step Ivs stepII.). 2-CV, two-chamberview;4-CV, four-chamber view;A, late transmitral fillingvelocity;
a′, late peak diastolic velocity of themitral annulus; ALM, area–lengthmodel; APVF, peak velocity of atrial reverse wave in pulmonary venous flow;
AVTI, velocity–time integral ofA; a′VTI, velocity–time integral of a′;DPVF, diastolic peak velocity of pulmonary venous flow; E, early transmitral filling
velocity; IPPV, intermittent positive pressure ventilation; LA-EF, left atrial emptying fraction; LA-FAC, left atrial fractional area change; MAP, mean
arterial pressure;MOD,methodofdiscs;NA,notapplicable;PE′CO2 , end-tidal concentrationof carbondioxide;SPVF, systolicpeakvelocityofpulmonary
venous flow
Baseline Spontaneous breathing (step I) IPPV (step II) P-value
Mean arterial pressure (mm Hg) 81 (8)*,† 67 (7)* 68 (7)† ,0.001
Heart rate (beats min21) 62 (10)† 67 (10)‡ 73 (12)†,‡ ,0.001
PE′CO2 (kPa) NA 6.8 (0.8) 4.7 (0.1) ,0.001
Maximum area, 4-CV (cm2) 14.9 (3.7)† 14.4 (3.8)‡ 12.3 (3.6)†,‡ 0.001
Minimum area, 4-CV (cm2) 7.5 (2.5) 7.7 (2.7) 7.5 (2.5) 0.810
Maximum area, 2-CV (cm2) 16.1 (4.7)† 15.4 (4.5)‡ 12.8 (4.1)†,‡ 0.001
Minimum area, 2-CV (cm2) 9.2 (3.4) 9.8 (3.1) 8.7 (3.1) 0.200
Maximum volume (cm3), MOD 45.4 (18.6)† 44.0 (16.7)‡ 34.5 (16.7)†,‡ 0.003
Minimum volume (cm3), MOD 18.4 (9.3) 19.6 (8.8) 17.7 (9.4) 0.595
Maximum volume (cm3), ALM 45.4 (16.5)† 43.1 (16.4) 36.3 (16.5)† 0.013
Minimum volume (cm3), ALM 18.4 (8.9) 19.1 (8.5) 18.5 (8.9) 0.895
LA-FAC, 4-CV (%) 51 (9)† 47 (10)‡ 40 (9)†,‡ ,0.001
LA-FAC, 2-CV (%) 45(8)† 37 (10)‡ 33 (10)†,‡ ,0.001
LA-EF (%), MOD 61 (9)† 56 (10)‡ 50 (11)†,‡ ,0.001
LA-EF (%), ALM 61 (10)† 56 (11)‡ 50 (11)†,‡ ,0.001
LA reservoir volume (ml) 27.5 (10.6)† 24.4 (10.2)‡ 17.1 (8.4)†,‡ ,0.001
LA conduit volume (ml) 69.5 (20.6) 68.7 (15.9) 62.0 (14.8) 0.085
LA active emptying volume (ml) 33.5 (12.6)*,† 25.8 (9.2)* 21.6 (7.8)† ,0.001
A (cm s21) 47 (10)*,† 40 (8)* 37 (10)† ,0.001
AVTI (cm) 4.1 (1.2)*
,† 3.2 (1.1)* 2.8 (1.0)† ,0.001
a′ (cm s21) 7.6 (1.5)*,† 6.1 (1.7)*,‡ 4.6 (1.6)†,‡ ,0.001
a′VTI (cm) 0.59 (0.13)*
,† 0.47 (0.16)*,‡ 0.36 (0.14)†,‡ ,0.001
LA filling fraction (%) 24 (6)*,† 20 (7)* 21 (8)† 0.003
SPVF (cm s
21) 54.5 (12.7)*,† 46.1 (12.4)*,‡ 17.8 (10.8)†,‡ ,0.001
DPVF (cm s
21) 55.6 (12.3) 57.2 (10.9) 53.5 (9.1) 0.891
APVF (cm s
21) 23.0 (3.8)† 21.3 (4.0)‡ 14.0 (10.8)†,‡ ,0.001
Ejection force (kdyn) 12.9 (5.8)*,† 8.9 (4.1)* 7.4 (4.1)† ,0.001
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desflurane, and isoflurane in concentrations of 1 MAC do not
relevantly affect LV systolic and diastolic function in healthy
adults free from cardiovascular diseases6 7 or in patients with
diastolic dysfunction.22 In contrast, the present study showed
a relevant impairment of active LA pump function, which is in
agreement with preliminary data in a recent own study.7
Wefoundno relevantdifferencesbetweensevoflurane,des-
flurane, and isoflurane regarding their effect on LA dimension
and function in the actual analyses. We, therefore, decided to
pool the data from all subjects, which are supported by
human and canine in vivo studies.6 7 10
Maximum LA area and volume were similar to baseline
whenvolatileanaestheticswereadministeredduringspontan-
eous breathing. Changing to IPPV significantly decreased
maximum LA area and volume. In contrast, active LA pump
function as evaluated by AVTI, A, a′, a′VTI, LA ejection force,
and filling fractionwere significantly decreased byadministra-
tion of volatile anaesthetics during spontaneous breathing.
Changing to IPPV differently affected the echocardiographic
parameters of LApump function.AVTI andAdidnot significant-
ly decrease during IPPV, whereas a′VTI and a′, which can be
used as a marker for global LA pump function,23 24 gave
evidence for a further significant impairment of LA function.
We might suggest that the preservation of the transmitral
forward flow (as assessed by A and AVTI) during IPPV
compared with spontaneous breathing occurred at the
expense of the markedly reduced retrograde flow into the






































Fig 3 Comparative changes of pump function and dimensions
between LA and LV. LA pump function as evaluated by late peak
diastolic velocity of the mitral annulus (a′) and LA fractional area
change (FAC) was significantly more impaired than LV pump func-
tion as evaluated by peak systolic velocity of themitral annulus (s′)
and LV FAC. Maximum LA area and end-diastolic area (EDA) of the
LVwere similarly affected by volatile anaesthetics during spontan-

























Active emptying volume Conduit volume
Step I
Step II
Fig2 Percentagechangesof reservoir, contractile, andconduit volumescomparedwithbaseline.Whereas reservoir volumedecreased significant-
ly only in step II (volatile anaesthetic and positive pressure ventilation), LA active emptying volume decreased significantly in both step I (volatile
anaesthetic and spontaneous breathing) and step II. Conduit volume did not change significantly during steps I and II. *P,0.025 vs baseline;
†P,0.025 vs step I.
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In agreement with the above-described findings, the LA
phasic volumes (reservoir, conduit, and active emptying
volume) were affected differently by volatile anaesthetics. LA
activeemptying volumewassignificantlydecreasedbyvolatile
anaesthetics during spontaneous breathing, whereas chan-
ging to IPPV resulted in a marked decrease in reservoir
volume. The passive LA conduit volume was not affected by
volatile anaesthetic during spontaneous breathing and IPPV.
These changes in LA phasic volumes are reflected by pulmon-
ary venous flow. SPFV, representing an index of LA reservoir
function,25 decreased in parallel with LA reservoir volume,
whereas DPVF, reflecting the conduit function,
25 remained un-
changed during all study steps. Thus, LV filling became less
active and more passive, which is in agreement with former
findings in an animal in vivo study.10
Altered loading conditions and relative hypovolaemia due to
vasodilation induced by volatile anaesthetics are unlikely to be
causative for our findings, as LA area and volume did not
change during spontaneous breathing, but enforce the rele-
vance of negative inotropic effect of the volatile anaesthetics
on active LA pump function. Two former studies in patients
undergoing haemodialysis showed that induced hypovolaemia
did not change A and a′ velocities.26 27 The different changes of
parameters of active LA pump function in non-anaesthetized
patients with hypovolaemia compared with the changes
found in our anaesthetized study population imply that our
findings cannot be simply explained by decreased LA preload
associated with blood volume distribution. Further, volatile
anaesthetics in spontaneously breathing patients will always
induce hypercapnia, which potentially influences LA function.
However, hypercapnia is an unlikely confounder, as previous
studieshave found thatarterial CO2 levelsdonot influencemyo-
cardial contractility and LV end-diastolic pressure in animals28
and in young healthy subjects.7 29 30 Hypercapnia has even
been found to increase late peak velocity of transmitral inflow
(A)30 due to sympathicoadrenergic stimulation. Therefore, the
depressive effects of volatile anaesthetics on this parameter
might have been even more pronounced if normocapnia had
been present during study step I.
The marked decrease in maximum and the unchanged
minimum LA volume during IPPV resulted in a significant de-
crease in LA reservoir volume. This reduction in LA volumes
can be caused by impaired LA relaxation and compliance, and
by external compression of the LA due to mechanical ventila-
tion.However, themost likelyexplanationsarethe redistribution
of circulating blood volume from the central compartment to
the periphery31 and the expiratory pooling of blood in the
pulmonary vascular bed, resulting in reduced LA filling after
changing to IPPV. The reduced preload might have altered LA
muscle mechanics due to reduced myocardial fibre length,
and therefore, further reduced LA pump function.
While our findings are in principle agreement with in vitro
findings8 and with animal studies,10 there are marked
differences in the magnitude of observed effects. We found a
reduction of about 10–20% in the different functional para-
meters under volatile anaesthetics at 1 MAC during spontan-
eous breathing and a reduction of about 20% to maximally
40% during IPPV (Fig. 3). This is substantially less than
described in a canine model showing a reduction in LA con-
tractility by approximately 50% at 1.2 MAC.11 Differences in
MAC, the use of additional cardiodepressive drugs as thiopen-
tal, open chest conditions, differences in ventilation, and in-
strumentation of the LA might have contributed to the more
pronounced effect of volatile anaesthetics in those animal
studies compared with our study. In fact, the enlargement of
the LA in another canine study10 suggests relevantmyocardial
depression, which was absent in our patients.
Further, our results are in agreementwith two clinical studies
in patients undergoing surgery under general anaesthesia,32 33
both suggesting impaired LA systolic function by volatile anaes-
thetics. However, these studies are limited due to the fact that
the authors compared preoperative TTE measurements with
intraoperative transoesophageal echocardiographic measure-
ments in ventilated patients anaesthetized with isoflurane in
combinationwith opioids, sedatives, and neuromuscular block-
ing agents. Moreover, the evaluation of the LA function was
solely based on transmitral A, mitral annular a′, or both
velocities.
In our previous humanstudies thatused the sameor similar
studymodels,6 7 22we found that LV functionwasnot relevant-
ly impaired by volatile anaesthetics, which is in contrast to
earlier animal studies. In the present study, we found signifi-
cantly different effects of volatile anaesthetics on LA vs LV
pump function. This is in disagreement with a former canine
Table 3 Inter- and intra-rater variabilities for echocardiographic parameters. Values are expressed as percentages (95% CI). P-values were
calculatedwith ANOVA for repeatedmeasurements. 4-CV, four-chamber view;A, late transmitral filling velocity; a′, late peak diastolic velocity of the
mitral annulus;AVTI, velocity–time integral ofA; EVTI, velocity–time integral of early transmitral filling velocity; EF, emptying fraction;MOD,method
of discs
Intra-rater variability P-value (within study steps) Inter-rater variability P-value (within study steps)
Maximum volume, 4-CV, MOD 7.8 (6.1–9.9) 0.871 7.6 (5.8–9.5) 0.559
Minimum volume, 4-CV, MOD 15.3 (11.6–19.0) 0.846 15.3 (11.1–19.6) 0.852
EF, MOD 11.2 (9.2–13.2) 0.147 10.1 (6.8–13.3) 0.199
A 8.8 (6.0–11.7) 0.419 3.7 (2.4–5.1) 0.941
AVTI 11.3 (9.0–13.7) 0.386 7.2 (4.7–9.6) 0.224
EVTI 7.5 (5.3–9.6) 0.182 6.2 (4.4–8.0) 0.224
a′ 8.1 (7.4–11.0) 0.652 3.8 (2.7–4.9) 0.976
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study9 10 suggesting similar effects of volatile anaesthetics on
the LA and LV. However, volatile anaesthetics decrease after-
load of the LV but not necessarily of the LA. Whereas LV-FAC
is well preserved, LA-FAC might be relevantly decreased by
impaired myocardial contractility due to volatile anaesthetics
or impaired LV diastolic function. However, we could not
show impaired diastolic function in the former study,7 and
there were also significant differences in the systolic TDI para-
meters of the LA (i.e. a′) and LV (i.e. s′).19 20 Further, the differ-
ence between LA-FAC and LV-FAC might underestimate the
real difference as they do not reflect the same function.
While LV-FAC results from systolic area change only, LA-FAC
includes both the passive and active LA function. Finally, myo-
cardialcells in theatriaandventriclesaremorphologically,mo-
lecularly and functionally distinct.34 Differences in contractility
between the atria and ventricles have been ascribed to the dif-
ferential regulation and expression of sarcoplasmic reticulum
calciumATPase.35 It seemsplausible that volatile anaesthetics
could, therefore, differently affect the inotropic action of atrial
and ventricular myocytes.21 To summarize, our findings
suggest different impairment of systolic pump function of the
LA and LV by volatile anaesthetics.
Strengths of this study include thehumanorigin of thedata,
the adequate power of the study, the standardized TTEassess-
ment based on current guidelines,13 and the established re-
search model both in awake and anaesthetized subjects
under mono-anaesthesia with volatile anaesthetics. Limita-
tions of the study include that this study is an additional ana-
lysis of echocardiographic data from a study, which aimed to
evaluate LV diastolic function. The study may have been con-
ducted slightly differently if LA function and volumes had
been the primary endpoints. Further, our TTE examinations
were limited to 2D echocardiography, pulsed-wave Doppler,
and TDI. The application of novel techniques such as LA
strain measurement by 2D or 3D speckle tracking might have
provided additional insight into changes in LA function and
geometry. Nevertheless, our results were consistent over a
broad range of echocardiographic parameters and according
to different assessments (e.g. MOD vs ALM, 4-CV vs 2-CV, con-
ventional Doppler vs TDI), which reinforces the relevance of
our findings. The inter-rater and intra-rater variabilities were
slightly higher compared with former own studies.6 7 22 36
However, the variabilities were comparable with reported
values in LA assessment in healthy subjects,37 38 and the
lower variabilities found ina recent study39havebeen favoured
by the markedly dilated LA present in those patients. In add-
ition, the variabilities were consistent within the three study
steps and overalmost everymeasured echocardiographic par-
ameter; this supports the credibility of our findings. Further,
volume measurements did not include the LA appendage
(LAA). In the absence of published evidence, onemight specu-
late that the LAA responded similarly to volatile anaesthetics
as the LA. However, even if that was not the case, LAA
volumesof reportedlyonly3ml inhealthyadults40makediffer-
ent behaviour of LAA an unlikely confounder of our results.
Another potential limitation is that an a-adrenergic agonist
(phenylephrine) was given to five participants due to
hypotensionduringechocardiographic evaluation. Theadmin-
istration of vasoactive drugs might potentially influence LA
function by positive inotropic effects on myocardium and
increased venous return.41 42 However, the low number of
patients treated with small doses of phenylephrine is unlikely
to be a confounder of our results. Further, heart rate slightly
increased during the study after changing to IPPV. However,
the observation that heart rate was not correlated with most
functional echocardiographic parameters, and that its correl-
ation with LA volumes and AVTI was weak questions the in-
crease in heart rate as a relevant confounder of our findings.
Finally, we included only young healthy patients without car-
diopulmonary diseases. Airway pressures were, therefore,
low in our patients, but increased ventilation pressures in
patients with pulmonary diseases might relevantly influence
LA function and volumes. The study was also not designed to
assess the clinical importance of the effects of volatile anaes-
thetics, and it remains unclear whether the effects of volatile
anaesthetics on LA dimension and functionmight be clinically
important, for example, in patients with impaired LV function
whoaremoredependent on the contributionof atrial function.
Potentially, the use of volatile anaesthetics might increase
the risk of intraoperative haemodynamic instability in such
patients.43
In conclusion, our study found that volatile anaesthetics
impair active LA pump function in healthy adults. LA
maximum dimensions decreased only after changing to IPPV,
and LA pump function was further impaired. The clinical im-
portance of these findings needs to be assessed in further
studies in patients with pre-existing cardiac dysfunction.
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